Literature DB >> 11297232

The diverse role of the ETS family of transcription factors in cancer.

D G Gilliland1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11297232

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  10 in total

1.  Quantitative Investigation of Protein-Nucleic Acid Interactions by Biosensor Surface Plasmon Resonance.

Authors:  Shuo Wang; Gregory M K Poon; W David Wilson
Journal:  Methods Mol Biol       Date:  2015

Review 2.  Signatures of DNA target selectivity by ETS transcription factors.

Authors:  Gregory M K Poon; Hye Mi Kim
Journal:  Transcription       Date:  2017-03-16

3.  Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to gamma-radiation.

Authors:  Anne Katrin Schauff; Ella L Kim; Jan Leppert; Roger Nadrowitz; Robin Wuestenberg; Mark Alexander Brockmann; Alf Giese
Journal:  J Neurooncol       Date:  2008-09-30       Impact factor: 4.130

Review 4.  PDEF and PDEF-induced proteins as candidate tumor antigens for T cell and antibody-mediated immunotherapy of breast cancer.

Authors:  Ashwani K Sood
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

5.  Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.

Authors:  Giuseppina M Carbone; Eileen M McGuffie; Angela Collier; Carlo V Catapano
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

6.  Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines.

Authors:  Manoj Munde; Shuo Wang; Arvind Kumar; Chad E Stephens; Abdelbasset A Farahat; David W Boykin; W David Wilson; Gregory M K Poon
Journal:  Nucleic Acids Res       Date:  2013-10-23       Impact factor: 16.971

7.  Systematic identification of transcription factors associated with patient survival in cancers.

Authors:  Chao Cheng; Lei M Li; Pedro Alves; Mark Gerstein
Journal:  BMC Genomics       Date:  2009-05-15       Impact factor: 3.969

8.  ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.

Authors:  G De la Houssaye; V Vieira; C Masson; F Beermann; J L Dufier; M Menasche; M Abitbol
Journal:  Mol Vis       Date:  2008-10-29       Impact factor: 2.367

9.  Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.

Authors:  Alka Mukhopadhyay; Thaer Khoury; Leighton Stein; Protul Shrikant; Ashwani K Sood
Journal:  Oncotarget       Date:  2013-04

10.  Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.

Authors:  Omar Abdel-Wahab; Jie Gao; Mazhar Adli; Anwesha Dey; Thomas Trimarchi; Young Rock Chung; Cem Kuscu; Todd Hricik; Delphine Ndiaye-Lobry; Lindsay M Lafave; Richard Koche; Alan H Shih; Olga A Guryanova; Eunhee Kim; Sheng Li; Suveg Pandey; Joseph Y Shin; Leon Telis; Jinfeng Liu; Parva K Bhatt; Sebastien Monette; Xinyang Zhao; Christopher E Mason; Christopher Y Park; Bradley E Bernstein; Iannis Aifantis; Ross L Levine
Journal:  J Exp Med       Date:  2013-11-11       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.